Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
US8927692B2 · kind B2 · utility
9Cited by
23References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 14, 2011 |
| Grant date | Jan 6, 2015 |
| Priority date | — |
| Expiry date | Nov 14, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are consensus amino acid sequences of prostate antigens that are capable of breaking tolerance in a targeted species, including PSA, PSMA, STEAP and PSCA antigens. Also provided are nucleic acid sequences that encode one or more consensus amino acid sequences of prostate antigens PSA, PSMA, STEAP and PSCA, as well genetic constructs/vectors and vaccines expressing the sequences. Also provided herein are methods for generating an autoimmune response against prostate cancer cells by administering one or more of the vaccines, proteins, and/or nucleic acid sequences that are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.